STAT

Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome

Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug? Find out on the latest episode of "The Readout…

Can biopharma police itself? Who decides whether something’s a disease or a difference? And will fecal matter ever become a drug?

We discuss all that and more on the latest

Citiți o mostră, înregistrați-vă pentru a citi în continuare.

Mai multe de la STAT

STAT1 min cititeMedical
STAT+: Pharmalittle: An Arthritis Drug Reduced Covid-19 Death Rates; Impatience Grows Over Choosing FDA Commissioner
Tocilizumab, a drug usually used to treat rheumatoid arthritis, reduced the rate of death in hospitalized Covid-19 patients in a major clinical trial.
STAT1 min cititeMedical
STAT+: Pharmalittle: Pause For J&J Covid-19 Shot To Continue At Least A Week; Biden Expands Candidate List For FDA Commish
The U.S. government pause on use of the Johnson & Johnson Covid-19 vaccine is unlikely to be lifted for at least another week or 10 days.
STAT1 min cititeMedical
STAT+: Pharmalittle: FDA Panel Endorses Moderna Covid-19 Vaccine; Sacklers Dodge Blame For Opioid Crisis At Hearing
An FDA advisory panel recommended the agency issue an emergency use authorization for the Moderna Covid-19 vaccine, all but guaranteeing the agency will do so.